Publications

Piña Y, Yadugiri S, Yeboa DN, Ferguson SD, Forsyth PA, Oliva ICG. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma. Curr Oncol Rep 24(1):43-54, 1/2022. e-Pub 1/2022. PMID: 35059999.

Upadhyay R, Liao K, Grosshans DR, McGovern SL, McAleer MF, Zaky W, Chintagumpala MM, Mahajan A, Yeboa DN, Paulino AC. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol. e-Pub 2/2022. PMID: 35157767.

Han EY, Wang H, Briere TM, Yeboa DN, Boursianis T, Kalaitzakis G, Pappas E, Castillo P, Yang J. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: An end-to-end test. J Appl Clin Med Phys 23(3):e13518, 3/2022. e-Pub 1/2022. PMCID: PMC8906207.

De B, Venkatesan AM, Msaouel P, Ghia AJ, Li J, Yeboa DN, Nguyen QN, Bishop AJ, Jonasch E, Shah AY, Campbell MT, Wang J, Zurita-Saavedra AJ, Karam JA, Wood CG, Matin SF, Tannir NM, Tang C. Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation. BJU Int 129(5):610-620, 5/2022. e-Pub 7/2021. PMID: 34228889. 

Halasz LM, Attia A, Bradfield L, Brat DJ, Kirkpatrick JP, Laack NN, Lalani N, Lebow ES, Liu AK, Niemeier HM, Palmer JD, Peters KB, Sheehan J, Thomas RP, Vora SA, Wahl DR, Weiss SE, Yeboa DN, Zhong J, Shih HA. Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. e-Pub 5/2022. PMID: 35902341.

Hasanov E, Yeboa DN, Tucker MD, Swanson TA, Beckham TH, Rini B, Ene CI, Hasanov M, Derks S, Smits M, Dudani S, Heng DYC, Brastianos PK, Bex A, Hanalioglu S, Weinberg JS, Hirsch L, Carlo MI, Aizer A, Brown PD, Bilen MA, Chang EL, Jaboin J, Brugarolas J, Choueiri TK, Atkins MB, McGregor BA, Halasz LM, Patel TR, Soltys SG, McDermott DF, Elder JB, Baskaya MK, Yu JB, Timmerman R, Kim MM, Mut M, Markert J, Beal K, Tannir NM, Samandouras G, Lang FF, Giles R, Jonasch E. An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma. CA Cancer J Clin. e-Pub 6/2022. PMID: 35708940.

Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, Beckham TH, Bishop AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W, Amini B. Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol:20220267. e-Pub 8/2022. PMID: 35946551.

Han EY, Yeboa DN, Briere TM, Yang J, Wang H. Dosimetric analysis of MR-LINAC treatment plans for salvage spine SBRT re-irradiation. J Appl Clin Med Phys:e13752. e-Pub 8/2022. PMID: 36004700. 

Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, Beckham TH, Bishio AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W, Amini B. Multidisciplinary management of spinal metastases: what the radiologist needs to know. Br J Radiol:20220266. e-Pub 8/2022. PMID: 35856792.

Nelson BE, Ejezie CL, Stephen BA, Nardo M, Campbell E, Gong J, Hong DS, Fu S, Yap TA, Murphy MB, Piha-Paul S, Daver NG, Rojas-Hernandez CM, Naing A. Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience. J Hematol. 2022 Jun;11(3):113-120. doi: 10.14740/jh1006. Epub 2022 Jun 2. PMID: 35837373; PMCID: PMC9275440.

Yeboa DN, Akinfenwa CA, Nguyen J, Amaya D, de Gracia B, Ning M, Cox V, De B, Smith BD, Lin L, Beddar S, Hoang H, Koong A, Liao Z. Effectively Conducting Oncology Clinical Trials during the COVID-19 Pandemic. Adv Radiat Oncol 6(3):100676, May-Jun, 5/2021. e-Pub 3/2021. PMCID: PMC7927592.

Taku N, Woodhouse KD, Liao KP, Anakwenze CP, Harrison RA, Zaky W, Paulino AC, Yeboa DN. Patterns of care for pediatric patients with newly-diagnosed grade II gliomas. Childs Nerv Syst 37(5):1563-1572, 5/2021. e-Pub 1/2021. PMID: 33404712.

Thrower SL, Al Feghali KA, Luo D, Paddick I, Hou P, Briere T, Li J, McAleer MF, McGovern SL, Woodhouse KD, Yeboa DN, Brock KK, Chung C. The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery. Adv Radiat Oncol 6(4):100708, Jul-Aug, 7/2021. e-Pub 4/2021. PMCID: PMC8175282. 

Han EY, Cardenas CE, Nguyen C, Hancock D, Xiao Y, Mumme R, Court LE, Rhee DJ, Netherton TJ, Li J, Yeboa DN, Wang C, Briere TM, Balter P, Martel MK, Wen Z. Clinical implementation of automated treatment planning for whole-brain radiotherapy. J Appl Clin Med Phys 22(9):94-102, 9/2021. e-Pub 7/2021. PMCID: PMC8425887.

de Almeida Bastos DC, Everson RG, de Oliveira Santos BF, Habib A, Vega RA, Oro M, Rao G, Li J, Ghia AJ, Bishop AJ, Yeboa DN, Amini B, Rhines LD, Tatsui CE. A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression. J Neurosurg Spine:1-9. e-Pub 1/2020. PMID: 31899882.

Cioffi G, Yeboa DN, Kelly M, Patil N, Manzoor N, Greppin K, Takaoka K, Waite K, Kruchko C, Barnholtz-Sloan JS. Epidemiology of vestibular schwannoma in the United States, 2004-2016. Neurooncol Adv 2(1):vdaa135, Jan-Dec, 1/2020. e-Pub 10/2020. PMCID: PMC7672330.

Boyce-Fappiano D, Gjyshi O, Pezzi TA, Allen PK, Solimman M, Taku N, Bernstein MB, Cabanillas ME, Amini B, Tatsui CE, Rhines LD, Wang XA, Briere TM, Yeboa DN, Bishop AJ, Li J, Ghia AJ. Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience. J Neurosurg Spine:1-9. e-Pub 2/2020. PMID: 32059183. 

Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Exclusion of Patients with Brain Metastases from Cancer Clinical Trials. Neuro Oncol 22(4):577-579, 4/2020. e-Pub 1/2020. PMCID: PMC7158639.

Milligan MG, Cronin AM, Colson Y, Kehl K, Yeboa DN, Schrag D, Chen AB. Overuse of Diagnostic Brain Imaging Among Patients With Stage IA Non-Small Cell Lung Cancer. J Natl Compr Canc Netw 18(5):547-554, 5/2020. PMID: 32380461.

Gjyshi O, Boyce-Fappiano D, Pezzi TA, Ludmir EB, Xiao L, Kaseb A, Amini B, Yeboa DN, Bishop AJ, Li J, Rhines LD, Tatsui CE, Briere TM, Ghia AJ. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol 148(2):327-334, 6/2020. e-Pub 5/2020. PMID: 32358642.

Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol 5(4):743-745, Jul-Aug, 7/2020. e-Pub 5/2020. PMCID: PMC7251361. 

Nantavithya C, Paulino AC, Liao K, McGovern SL, Grosshans DR, McAleer MF, Woodhouse KD, Khatua S, Chintagumpala MM, Majd NK, Yeboa DN. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer 67(8):e28373, 8/2020. e-Pub 5/2020. PMID: 32453481.

Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg 141:e133-e144, 9/2020. e-Pub 5/2020. PMID: 32407910.

Yeboa DN, Gibbs IC. Stereotactic Radiotherapy and Resection of Brain Metastases: The Role of Hypofractionation. JAMA Oncol. e-Pub 10/2020. PMID: 33057588.

Diao K, Song J, Thall PF, McGinnis GJ, Boyce-Fappiano D, Amini B, Brown PD, Yeboa DN, Bishop AJ, Li J, Briere TM, Tatsui CE, Rhines LD, Chang EL, Ghia AJ. Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. Radiother Oncol 152:49-55, 11/2020. e-Pub 7/2020. PMID: 32745668. 

Lin TA, Ludmir EB, Liao KP, McAleer MF, Bishop AJ, Grosshans D, McGovern S, Woodhouse KD, Paulino AC, Yeboa DN. Relationship between treatment center case volume and survival for localized Ewing sarcoma: The role of radiotherapy timing. Pediatr Blood Cancer 67(11):e28685, 11/2020. e-Pub 9/2020. PMID: 32881378.

Patil N, Kelly ME, Yeboa DN, Buerki RA, Cioffi G, Balaji S, Ostrom QT, Kruchko C, Barnholtz-Sloan J. Epidemiology of Brainstem High-Grade Gliomas in Children and Adolescents in the United States, 2000-2017. Neuro Oncol. e-Pub 12/2020. PMID: 33346835.

Bastos DCA, Vega RA, Traylor JI, Ghia AJ, Li J, Oro M, Bishop AJ, Yeboa DN, Amini B, Kumar VA, Rao G, Rhines LD, Tatsui CE. Spinal laser interstitial thermal therapy: single-center experience and outcomes in the first 120 cases. J Neurosurg Spine:1-10. e-Pub 12/2020. PMID: 33307530.

Han EY, Aima M, Hughes N, Briere TM, Yeboa DN, Castillo P, Wang J, Yang J, Vedam S. Feasibility of spinal stereotactic body radiotherapy in Elekta Unity® MR-Linac. J Radiosurg SBRT 7(2):127-134, 2020. PMCID: PMC7717094. 

Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Garcia MM, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado M. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. Neurooncol Adv 3(1):vdab079, Jan-Dec, 1/2021. e-Pub 6/2021. PMCID: PMC8350154.

Nantavithya C, Paulino AC, Liao K, Woodhouse KD, McGovern SL, Grosshans DR, McAleer MF, Khatua S, Chintagumpala MM, Majd N, Zaky W, Yeboa DN. Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis. Cancer. e-Pub 3/2021. PMID: 33721338.

De B, Kaiser KW, Ludmir EB, Yeboa DN, Tang C, Hoffman KE, Liao Z, Koong AC, Smith BD. Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncol 60(3):1-4, 3/2021. e-Pub 12/2020. PMID: 33356801.

Miccio JA, Wilson LD, Kann BH, Jairam V, Beckta J, Foss FM, Yeboa DN. Cutaneous T-Cell Lymphoma: Trends in Radiation Doses and Patterns of Care 2004-2015. Anticancer Res 39(1):253-259, 1/2019. PMID: 30591466. 

Yeboa DN, Liao KP, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines LD, Ferguson S, Paulino AC, Ghia AJ. National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas. World Neurosurg. e-Pub 1/2019. PMID: 30641236.

Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clin Transl Radiat Oncol 15:46-52, 2/2019. e-Pub 12/2018. PMCID: PMC6329703.

Yeboa DN, Liao Z, Court L, Holliday E, Spelman A, Herman J. Protocol-in-a-Day Workshop: A “Lean" Approach to Clinical Trial Development and Focus on Junior Faculty Development. Advances in Radiation Oncology 4(3):439-442, 3/2019. e-Pub . PMID: doi: 10.1016/j.adro.201.

Rahimy E, Weidhaas J, Wei W, Lannin D, Horowitz N, Higgins S, Wilson LD, Knowlton C, Moran MS, Young MR, Killelea B, Chagpar A, Yeboa DN, Zelterman D, Evans S. Patient Reported Outcomes and Cosmesis in a Feasibility Study of 4D Simulated Image Guided Accelerated Partial Breast Irradiation (APBI). Pract Radiat Oncol 9(3):e257-e265, 5/2019. e-Pub 2/2019. PMID: 30796975. 

Lin TA, Ludmir EB, Liao KP, McAleer MF, Grosshans DR, McGovern SL, Bishop AJ, Woodhouse KD, Paulino AC, Yeboa DN. Timing of Local Therapy Impacts Survival in Ewing Sarcoma. Int J Radiat Oncol Biol Phys 104(1):127-136, 5/2019. e-Pub 12/2018. PMID: 30593906.

Yeboa DN, Liao Z, Court L, Holliday EB, Spelman A, Herman J. Protocol-in-a-Day Workshop: A Lean Approach to Clinical Trial Development and Focus on Junior Faculty Development. Adv Radiat Oncol 4(3):439-442, Jul-Sep, 7/2019. e-Pub 3/2019. PMCID: PMC6639744.

Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol 16(8):521-522, 8/2019. e-Pub 5/2019. PMID: 31150024.

Traylor JI, Habib A, Patel R, Muir M, Gadot R, Briere T, Yeboa DN, Li J, Rao G. Fractionated stereotactic radiotherapy for local control of resected brain metastases. J Neurooncol 144(2):343-350, 9/2019. e-Pub 7/2019. PMID: 31313060. 

Shaverdian N, Yeboa DN, Gardner L, Harari PM, Liao K, McCloskey S, Tuli R, Vapiwala N, Jagsi R. Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences. J Oncol Pract 15(12):e1010-e1017, 12/2019. e-Pub 11/2019. PMID: 31747336.

Han EY, Kim GY, Rebueno N, Yeboa DN, Briere TM. End-to-end testing of automatic plan optimization using RayStation scripting for hypofractionated multi-metastatic brain stereotactic radiosurgery. Med Dosim 44(4):e44-e50, Winter, 2019. e-Pub 1/2019. PMID: 30655170.

Al Feghali KA, Yeboa DN, Chasen B, Gule MK, Johnson JM, Chung C. The Use of 68Ga-DOTATATE PET/CT in the Non-Invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. Front Oncol 8:454, 2018. e-Pub 10/2018. PMCID: PMC6198069.

Kann BH, Park HS, Yeboa DN, Aneja S, Girardi M, Foss FM, Roberts KB, Wilson LD. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome. Clin Lymphoma Myeloma Leuk 17(8):520-526.e2, 8/2017. e-Pub 6/2017. PMID: 28655598. 

Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas. Radiother Oncol 125(2):258-265, 11/2017. e-Pub 10/2017. PMID: 29054377.

Kole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme. Cancer 122(15):2364-70, 8/2016. e-Pub 5/2016. PMID: 27172136.

Lester-Coll NH, Park HS, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim SP, Gross CP, Yu JB. The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer. Urology 96:128-135, 10/2016. e-Pub 7/2016. PMID: 27392652.

Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children. JAMA Oncol 2(12):1574-1581, 12/2016. e-Pub 8/2016. PMID: 27491009. 

Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009. Am J Clin Oncol 39(6):568-574, 12/2016. e-Pub 5/2014. PMID: 24879475.

Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM, Becker KP, Yu JB, Bindra RS, Roberts KB. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro Oncol 19(2):259-269, 2/2017. e-Pub 8/2016. PMCID: PMC5464064.

Yeboa DN, Aneja S, Montana G, Roberts K, Yu J. Historical Trends in Radiotherapy Use in Prevalent Malignancies over 38 years in SEER. Journal of Radiation Oncology 4(11), DOI 10.1007/s13566-015-0182-y, 1/2015. e-Pub 1/2015.

Rutter CE, Lester-Coll NH, Mancini BR, Corso CD, Park HS, Yeboa DN, Gross CP, Evans SB. The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer. Cancer 121(14):2331-40, 7/2015. e-Pub 3/2015. PMID: 25810128. 

Rutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation. Lung Cancer 90(2):243-8, 11/2015. e-Pub 8/2015. PMID: 26277031.

Rutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base. Cancer 121(23):4141-9, 12/2015. e-Pub 8/2015. PMID: 26280559.

Yeboa DN, Evans SB. Contemporary Breast Radiotherapy and Cardiac Toxicity. Semin Radiat Oncol 26(1):71-8, 1/2016. e-Pub 9/2015. PMID: 26617212.

Rutter CE, Corso CD, Park HS, Mancini BR, Yeboa DN, Lester-Coll NH, Kim AW, Decker RH. Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States. Lung Cancer 85(3):390-4, 9/2014. e-Pub 6/2014. PMID: 25001510. 

Bekelman JE, Mitra N, Efstathiou J, Liao K, Sunderland R, Yeboa DN, Armstrong K. Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys 81(4):e325-34, 11/2011. e-Pub 4/2011. PMCID: PMC4265571.

Yeboa DN, Guzzo T, Mitra N, Christodouleas JP, Haas NB, Vapiwala N, Armstrong K, Bekelman JE. Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology 78(5):1107-13, 11/2011. e-Pub 9/2011. PMID: 21943872. 

Farooqi A, Li J, de Groot J, Yeboa DN. Current Role of Radiation Therapy in the Management of Malignant Central Nervous System Tumors. Hematol Oncol Clin North Am 34(1):13-28, 2/2020. e-Pub 10/2019. PMID: 31739940.

Yeboa DN, Shah AY. Managing Perplexing Intracranial Lesions. Int J Radiat Oncol Biol Phys 105(2):24, 10/2019. PMID: 31492380.

Yeboa DN and Sulman E. “Update on radiation combinations in the treatment of patients with malignant brain tumors: from Radiosensitizers to immunotherapy". World Federation of Neuro-Oncology Societies Magazine, WFNOS Volume 2(Issue 3):ISSN 2518-6507, WFNOS Magazine Volume 2 (2017) Issue 3. e-Pub 11/2017.

Farooqi A, Yeboa DN, Sulman. Pituitary Adenoma and Craniopharyngioma. In: Pocket Radiation Oncology. 1, 1. Ed(s) Tang C and Farooqi A. Wolters Kluwer, 3-15, 2019.

Farooqi A, Yeboa DN, Sulman. Meningioma. In: Pocket Radiation Oncology. 1, 1. Ed(s) Tang C and Farooqi A. Wolters Kluwer, 3-8, 2019.

Farooqi A, Yeboa DN, Sulman. Low Grade Gliomas. In: Pocket Radiation Oncology. 1, 1. Ed(s) Tang C and Farooqi A. Wolters Kluwer, 3-1, 2019. PMID: 9781496398574.

Farooqi A, Yeboa DN, Sulman. High Grade Gliomas. In: Pocket Radiation Oncology. 1, 1. Ed(s) Tang C and Farooqi A. Wolters Kluwer, 3-4, 2019. PMID: 9781496398574.

Ferguson SD, Everson R, Wagner K, Yeboa DN, McCutcheon IE, Sawaya R. Neurosurgical Management of Single Brain Metastases. In: Adult CNS Radiation Oncology: Principles and Practice. 1, 1st. Ed(s) EL Chang, PD Brown, SS Lo, A Sahgal, JH Suh. Springer: Switzerland, 431-448, 2018. PMID: 978-3319428772.

Yeboa DN, Young M, Damast, S. Vaginal Cancer. In: Pocket Guide to Radiation Oncology, 1st. Ed(s) D Chamberlain, JB Yu, R Decker. Demos Medical Publishing, 2016. PMID: 978-1620700891 (ISBN-13).